HRTX (HRTX)
Quantitative Summary
DeterministicBelow-average fundamentals indicated by Piotroski score of 3/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
ETF Contagion Visualizer
Simulate a price drop in HRTX to visualize passive redemption contagion across ETFs and collateral stocks.
If HRTX (HRTX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Eli Lilly & Co. (LLY) as the most exposed collateral stock, sharing 1 ETFs with HRTX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
HRTX Ownership Dynamics
ETFs with Highest HRTX Exposure
Float lock-up computed from 1 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 79,835 | $0.96 | $76,641.6 |
| 2026-05-08 | 125,158 | $1.24 | $155,195.92 |
| 2026-05-07 | 246,572 | $1.31 | $323,009.32 |
| 2026-05-06 | 226,428 | $1.23 | $278,506.44 |
| 2026-05-04 | 10,064 | $1.27 | $12,781.28 |
| 2026-04-28 | 42,298 | $1.19 | $50,334.62 |
| 2026-04-24 | 1,985 | $1.00 | $1,985 |
| 2026-04-23 | 76,361 | $1.02 | $77,888.22 |
| 2026-04-21 | 2,800 | $1.05 | $2,940 |
| 2026-04-20 | 2,103 | $1.00 | $2,103 |
| 2026-04-17 | 1,993 | $0.94 | $1,873.42 |
| 2026-04-15 | 249,579 | $0.94 | $234,604.26 |
| 2026-04-13 | 5,439 | $0.85 | $4,623.15 |
| 2026-04-10 | 186,667 | $0.82 | $153,066.94 |
| 2026-04-08 | 3,246 | $0.79 | $2,564.34 |
| 2026-04-07 | 11,038 | $0.81 | $8,940.78 |
| 2026-04-06 | 5,696 | $0.80 | $4,556.8 |
| 2026-04-02 | 12,702 | $0.80 | $10,161.6 |
| 2026-03-31 | 37,729 | $0.75 | $28,296.75 |
| 2026-03-30 | 8,767 | $0.78 | $6,838.26 |
| 2026-03-27 | 49,602 | $0.83 | $41,169.66 |
| 2026-03-19 | 61,322 | $0.84 | $51,510.48 |
| 2026-03-16 | 138,715 | $0.88 | $122,069.2 |
| 2026-03-13 | 76,187 | $0.93 | $70,853.91 |
| 2026-03-12 | 62,436 | $0.97 | $60,562.92 |
| 2026-03-10 | 200,199 | $1.00 | $200,199 |
| 2026-02-27 | 281,326 | $1.20 | $337,591.2 |
| 2026-02-09 | 6,634 | $1.26 | $8,358.84 |
| 2026-02-04 | 2,031 | $1.37 | $2,782.47 |
| 2026-01-30 | 18,505 | $1.34 | $24,796.7 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare HRTX to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.